Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-27 Sale | 2024-03-28 12:18 pm | Vir Biotechnology Inc. | VIR | Lee Sung EVP & Chief Financial Officer | 6,008 | $9.8875 | $59,404 | 100,492 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-03 Tax Withholding | 2024-12-05 4:30 pm | N/A N/A | CYTOKINETICS INC | CYTK | Lee Sung EVP, Chief Financial Officer | 1,536 | $51.51 | 41,755 (Direct) | View |
| 2024-12-03 Option Award | 2024-12-05 4:30 pm | N/A N/A | CYTOKINETICS INC | CYTK | Lee Sung EVP, Chief Financial Officer | 8,607 | $0 | 41,755 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-03 5:07 pm | 2025-06-02 2034-05-30 | CYTOKINETICS INC | CYTK | Lee Sung EVP, Chief Financial Officer | 88,101 | $0 | 88,101 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 7:32 pm | N/A 2034-02-21 | Vir Biotechnology Inc. | VIR | Lee Sung EVP & Chief Financial Officer | 120,000 | $0 | 186,500 (Direct) | View |
| 2023-03-27 Option Award | 2023-03-29 5:49 pm | N/A 2033-03-26 | Vir Biotechnology Inc. | VIR | Lee Sung Chief Financial Officer | 199,500 | $0 | 199,500 (Direct) | View |
| 2020-11-25 Tax Withholding | 2020-11-30 7:46 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Lee Sung EVP, Chief Financial Officer | 5,042 | $9.77 | 88,708 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:31 pm | N/A 2030-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Lee Sung EVP, Chief Financial Officer | 150,500 | $0 | 194,250 (Direct) | View |